Surgery – Means for introducing or removing material from body for... – Treating material introduced into or removed from body...
Patent
1990-06-20
1992-04-28
Coven, Edward M.
Surgery
Means for introducing or removing material from body for...
Treating material introduced into or removed from body...
604102, 606194, A61M 3100
Patent
active
051083655
ABSTRACT:
Provided is an improved method of percutaneous transluminal balloon coronary angioplasty for dilating a narrowed portion of an artery. According to the method a multi-lumen inflatable balloon catheter having a predetermined balloon size and shape when inflated is introduced into the lumen of an artery in the patient and advanced until it is in the region of arterial narrowing. The balloon is then inflated for a pre-determined amount of time. According to a preferred embodiment the balloon is inflated for from about 1 to about 5 minutes. The inflated balloon deforms the adjacent narrowed portion of the artery and, in doing so, also blocks the blood flow through the artery. Into the lumen of the artery, immediately past the blockage created by the inflated balloon, an effective amount of a pharmaceutically acceptable magnesium preparation is then injected.
REFERENCES:
patent: 4299226 (1981-11-01), Banka
patent: 4376117 (1983-03-01), Godfraind et al.
patent: 4512762 (1985-04-01), Spears
patent: 4531936 (1985-07-01), Gordon
patent: 4651738 (1987-03-01), Demer et al.
patent: 4773899 (1988-09-01), Spears
patent: 4777951 (1988-10-01), Cribier et al.
patent: 4799479 (1989-01-01), Spears
patent: 4824436 (1989-04-01), Wolinsky
patent: 4975279 (1990-12-01), Schumacher
patent: 5008284 (1991-04-01), Grover
Anjani Dubey, et al., Magnesium, Myocardial Ischaemia and Arrhythmias, Drugs, vol. 37, pp. 1-7 (1989).
N. Ferrara et al., Electrical and Mechanical Actions of Magnesium Sulfate During Ischemia and Reperfusion on Isolated Perfused Rat Heart, Arch. Int. Pharmacodyn, vol. 293, pp. 84-96 (1988).
George E. Billman et al., Prevention of Ventricular Fibrillation with Magnesium Sulfate, European Journal of Pharmacology, vol. 158, pp. 167-171 (1988).
H. Sandvad Rasmussen et al., Intravenous Magnesium in Acute Myocardial Infarction, The Lancet, pp. 234-236, Feb. 1, 1986.
L. F. Smith et al., Intravenous Infusion of Magnesium Sulphate After Acute Myocardial Infarction: Effects on Arrhythmias and Mortality, International Journal of Cardiology, vol. 12, pp. 175-180 (1986).
Celia Chang et al., Magnesium Deficiency and Myocardial Infarct Size in the Dog, JACC, vol. 5, No. 2, pp. 280-289, Feb. 1985.
Burton M. Altura, Ischemic Heart Disease and Magnesium, Mini Reviews, Magnesium, vol. 7, pp. 57-67 (1988).
Bernard Horn, Magnesium and the Cardiovascular System, Magnesium, vol. 6, pp. 109-111 (1987).
Barbara Chipperfield et al., Magnesium and the Heart, American Heart Journal, vol. 93, No. 6, pp. 679-682 (1977).
B. M. Altura, Sudden-Death Ischemic Heart Disease and Dietary Magnesium Intake: Is the Target Site Coronary Vascular Smooth Muscle?, Medical Hypotheses, vol. 5, No. 8, pp. 843-848 (1979).
Prasad, D. M. V. Turlapaty et al., Magnesium Deficiency Produces Spasms of Coronary Arteries: Relationship to Etiology of Sudden Death Ischemic Heart Disease, Science, vol. 208, pp. 198-200 (1980).
Dan Tzivoni, et al., Magnesium Therapy for Torsades de Pointes, The American Journal of Cardiology, vol. 53, pp. 528-530 (1984).
Leon F. Kraft, et al., Attenuation by Magnesium of the Electrophysiologic Effects of Hyperkalemia on Human and Canine Heart Cells, The American Journal of Cardiology, vol. 45, pp. 1190-1191 (1980).
W. Thomas Woods, et al., Electrophysiological Effects of Magnesium on Cells in the Canine Sinus Node and False Tendon, Circulation Research, vol. 44, p. 183 (1979).
R. E. Katholi, et al., Dual Dependence on Both Ca.sup.2+ and Mg.sup.2+ for Electrical Stability in Cells of Canine False Tendon, Journal of Molecular and Cellular Cardiology, vol. 11, pp. 436-437 (1979).
W. T. Woods, et al., Preservation of Resting Potential by Magnesium in Hypoxic Canine Cardiac Cells, Magnesium, vol. 4, pp. 96-97 (1985).
S. Bloom, Effects of Magnesium Deficiency on the Pathogenesis of Myocardial Infarction, Magnesium, vol. 5, pp. 154-164 (1986).
Bjarne Bo Jeppesen, Magnesium Status in Patients with Acute Myocardial Infarction: A Pilot Study, Magnesium, vol. 5, pp. 95-100 (1986).
Irshad H. Chaudry, et al., The Role of ATP-Magnesium in Ischemia and Shock, Magnesium, vol. 5, pp. 211-220 (1986).
Ronald J. Korthuis et al., Vascular Injury in Dogs During Ischemia-Reperfusion: Improvement with ATP-MgCl2 Pretreatment, The American Physiological Society, pp. H702-H708 (1988).
Makoto Sunamori, et al., Effect of Magnesium in Cardioplegic Solution Upon Hypothermic Ischemic Myocardial MitochondriaJapanese Circulation Journal, vol. 44, pp. 81-86 (1980).
Coven Edward M.
Passaniti Sebastiano
LandOfFree
Transluminal infusion of magnesium during coronary angioplasty does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Transluminal infusion of magnesium during coronary angioplasty, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Transluminal infusion of magnesium during coronary angioplasty will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1244509